Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Ghrelin involved in mood responses to stress

July 8, 2008

Anesiva launches Zingo for pain reduction in i.v. line placements in children

July 7, 2008

Evotec reports top-line results from phase Ib dose safety study of EVT-101

July 7, 2008

Merck & Co. discloses results from recent clinical studies with telcagepant

July 7, 2008

Novel orally inhaled dihydroergotamine for migraine safe in asthmatics

July 7, 2008

Labopharm submits complete response to FDA in relation to appeal process for tramadol

July 7, 2008

Tapentadol IR demonstrates efficacy and safety in pain clinical studies

July 7, 2008

Spheramine fails to meet endpoints in phase IIb STEPS trial in PD

July 4, 2008

ASIC1a a potential target for reducing seizures

July 4, 2008

New agents for Alzheimer's disease and other neurological disorders reported in recent patents

July 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...